Bactericidal activity of cefotaxime, desacetylcefotaxime, rifampin, and various combinations tested at cerebrospinal fluid levels against penicillin-resistant Streptococcus pneumoniae

Diagnostic Microbiology and Infectious Disease

Volumn 22, Issue 1-2, 1995, Pages 119-123

  Cormican, Martin G ^a   Erwin, Meridith E ^a   Jones, Ronald N ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CHLORAMPHENICOL; DEACETYLCEFOTAXIME; PENICILLIN G; RIFAMPICIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; BACTERICIDAL ACTIVITY; CEREBROSPINAL FLUID; CONFERENCE PAPER; CONTROLLED STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

ANTIBIOTICS; ANTIBIOTICS, ANTITUBERCULAR; ANTIBIOTICS, COMBINED; ANTIBIOTICS, GLYCOPEPTIDE; CEFOTAXIME; CEFTAZIDIME; CEPHALOSPORINS; CHLORAMPHENICOL; DRUG INTERACTIONS; HUMAN; MENINGITIS, PNEUMOCOCCAL; MICROBIAL SENSITIVITY TESTS; PENICILLIN RESISTANCE; RIFAMPIN; STREPTOCOCCUS PNEUMONIAE; VANCOMYCIN;

EID: 0029164498     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/0732-8893(95)00044-B     Document Type: Article

References (23)

1. Antimicrobial resistance in Streptococcus pneumoniae An overview
2. Antibiotic-resistant pneumococci: facts and fiction
3. Ceftriaxone failure in meningitis caused by Streptococcus pneumoniae with reduced susceptibility to beta-lactam antibiotics
4. Comparison of antibiotic combinations against penicillin-resistant pneumococci
5. Correlation of in vitro time kill curves and kinetics of bacterial killing in cerebrospinal fluid during ceftriaxone therapy of experimental Escherichia coli meningitis
6. In vitro killing activities of antibiotics at clinically achievable concentrations in cerebrospinal fluid against penicillin-resistant Streptococcus pneumoniae isolated from children with meningitis
7. A pneumococcal clinical isolate with high level resistance to cefotaxime and ceftriaxone
8. Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis
9. Time-kill studies of antibiotic combinations against penicillin-resistant and -susceptible Streptococcus pneumoniae
10. Cerebrospinal fluid penetration of amikacin in children with community-acquired bacterial meningitis
11. Treatment and diagnosis of infections caused by drug-resistant Streptococcus pneumoniae
12. Pneumococcal resistance to antimicrobial agents in the province of Quebec, Canada
13. Activity of six contemporary antibacterial agents against 96 isolates from purulent meningitis: the contribution of desacetylcefotaxime to antimicrobial potency
14. Prevalence of important pathogens and antimicrobial activity of parenteral drugs at numerous centers in the United States. I. Study on the threat of emerging resistances: real or perceived
15. Detection of antimicrobial resistance in Streptococcus pneumoniae by use of standardized susceptibility testing methods and recently developed interpretive criteria
16. Comparison of antimicrobial susceptibility methods for detection of penicillin-resistant Streptococcus pneumoniae
17. Pharmacokinetics, cerebrospinal fluid concentration and safety of intravenous rifampin in pediatric patients undergoing shunt placements
18. Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococci
19. Cephalosporin treatment failure in penicillin and cephalosporin-resistant Streptococcus pneumoniae meningitis
20. Cefotaxime and desacetylcefotaxime pharmacokinetics in infants and children with meningitis
21. Characteristics and antibiotic therapy of adult meningitis due to penicillin-resistant pneumococci
22. Cefotaxime therapy of bacterial meningitis in children